Immune health supplements market expected to reach $58 billion by 2032 with 9.8% CAGR

From GlobeNewswire: 2024-12-03 08:20:00

The immune health supplements market was valued at USD 25.3 billion in 2023, with a projected CAGR of 9.8% from 2024 to 2032. These supplements aim to boost the immune system, reduce illness severity, and promote overall health. Factors driving market growth include rising chronic disease prevalence, aging populations seeking immune support, and advancements in supplement formulations.

The market is segmented into categories like vitamins, minerals, herbs, probiotics, amino acids, and omega-3 fatty acids. Vitamins, worth USD 7.3 billion in 2023, dominate the market due to their crucial role in immune function. Capsules, with a 34.2% market share in 2023, offer better bioavailability, ensuring quick nutrient absorption.

North America is expected to lead the market, with the U.S. generating USD 9.4 billion in revenue in 2023. Chronic diseases drive demand, while regulatory oversight ensures product safety. Major players in the market include Abbott Laboratories, Bayer, Danone, and Nestlé, among others. Industry insights cover growth drivers, challenges, regulatory and technological landscapes, and future market trends.



Read more at GlobeNewswire: Immune Health Supplements Market to hit USD 58 billion by